The effect of ABV regimen on CD4 lymphocyte count in patients with advanced HIV related Kaposi’s sarcoma

By Lin Lin   Dharmadhikari Datta   Paleske Alexander  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 6, 2011-06 ,pp. : 366-368

Springer Publishing Company

Access to resources Recommend Favorite

Clinical aspects and management of AIDS-related Kaposi's sarcoma

By Levine A.M.   Tulpule A.  

European Journal of Cancer, Vol. 37, Iss. 10, 2001-07 ,pp. : 1288-1295

Elsevier

Access to resources Recommend Favorite

Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin

By Hengge U.R.   Esser S.   Rudel H.-P.   Goos M.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 878-883

Elsevier

Access to resources Recommend Favorite

Treatment of Poor Prognosis Epidemic Kaposi's Sarcoma with Doxorubicin, Bleomycin, Vindesine and Recombinant Human Granulocyte-Monocyte Colony Stimulating Factor (rh GM-CSF)

By Bakker P.J.M.   Danner S.A.   Napel C.H.H.t.   Kroon F.P.   Sprenger H.G.   van Leusen R.   Meenhorst P.L.   Muusers A.   Veenhof C.H.N.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 188-192

Elsevier

Access to resources Recommend Favorite

Paclitaxel induces apoptosis in AIDS-related Kaposi's sarcoma cells

By Cai Jie   Zheng Tong   Masood Rizwan   Smith D. Lynne   Hinton David R.   Kim Caryn Nae   Fang Guofu   Bhalla Kapil   Gill Parkash S.  

Sarcoma, Vol. 4, Iss. 1-2, 2000-03 ,pp. : 37-45

Informa Healthcare

Access to resources Recommend Favorite